Individual Tumor Profiling
Has Tumor Molecular Profiling Enabled More Effective and Less Toxic Cancer Treatment?
Top 10 Under 40
Up-and-Coming Stars Shine in Biopharma Research and Business
Podcast: FDA’s New Commissioner Hits the Ground Running
Scott Gottlieb, M.D., Commits to Speeding Up Drug Reviews, and Maintaining Safety and Efficacy
Liquid Biopsies Remain Wait and See for Some Clinicians
Circulating Biomarker Assays Promise to Refresh Cancer Profiling and Monitoring Practices
For full access to this article login to GEN Select now.
Company Update: Ludesi Proffers Software and Services
Business Model Set Up to Circumvent Product Accuracy and Ease-of-use Compromise
- Ludesi (www.ludesi.com) recently reported a contract with DSM (www.dsmnutritionalproducst.com) to carry out image analysis of the latter’s 2-D protein gels. The deal, Ludesi says, is further validation of its approach to analyzing images from 2-D electrophoresis gels on a per-sample basis. Ludesi pioneered the concept of performing analyses ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.